Establishment Labs Holdings Inc. (ESTA)
NASDAQ: ESTA · Real-Time Price · USD
45.40
-0.84 (-1.82%)
Dec 27, 2024, 11:29 AM EST - Market open

Company Description

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery.

The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.

The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia.

Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Establishment Labs Holdings Inc.
Establishment Labs Holdings logo
Country Costa Rica
Founded 2004
IPO Date Jul 19, 2018
Industry Medical Devices
Sector Healthcare
Employees 908
CEO Juan Chacon Quiros

Contact Details

Address:
Building B15 and 25, Coyol Free Zone
Alajuela
Costa Rica
Phone 506 2434 2400
Website establishmentlabs.com

Stock Details

Ticker Symbol ESTA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001688757
CUSIP Number G31249108
ISIN Number VGG312491084
Employer ID 98-1436377
SIC Code 3842

Key Executives

Name Position
Juan Jose Chacon Quiros Founder, Chief Executive Officer and Executive Director
Rajbir Singh Denhoy Chief Financial Officer
S. Ross Mansbach General Counsel, Chief Compliance Officer and Chief Human Resources Officer
Filippo Caldini President
Roberto de Mezerville Chief Technology Officer
Salvador Santos Dada Head of Special Projects
Rosalyn Cole d'Incelli SVice President of Global Clinical, Medical and US Regulatory Affairs
Ivan Bilic Senior Vice President of Commercial Operations - OUS
Jeff Ehrhardt Senior Vice President and GM of North America
Neeta Toprani Corporate Secretary

Latest SEC Filings

Date Type Title
Nov 14, 2024 SCHEDULE 13G/A Filing
Nov 12, 2024 10-Q Quarterly Report
Nov 12, 2024 8-K Current Report
Nov 12, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 12, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 8, 2024 424B5 Filing
Nov 7, 2024 8-K Current Report
Nov 7, 2024 8-K Current Report
Sep 26, 2024 8-K Current Report
Aug 26, 2024 8-K Current Report